TY - JOUR
T1 - Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice
T2 - A possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia
AU - Li, Zhimin
AU - Liang, Yanqi
AU - Boules, Mona
AU - Gordillo, Andres
AU - Richelson, Elliott
N1 - Funding Information:
We would like to thank Dr. Tomofumi Miura for technical support. This work was supported by NIMH grant MH71241 .
PY - 2010/6
Y1 - 2010/6
N2 - Neurotensin (NT) is a tridecapeptide that acts as a neuromodulator in the central nervous system mainly through two NT receptors: NTS1 and NTS2. The present study was done to determine the roles of NTS1 and NTS2 on amino acid release in striatum with the use of NTS1 or NTS2 knockout (-/-) mice given d-amphetamine. Both NTS1-/- and NTS2-/- mice had lower extracellular concentrations of d-serine in striatum than did wild type (WT) mice. NTS2-/- but not NTS1-/- mice also had significantly lower basal concentrations of glutamate in striatum as compared to that for WT mice. Systemic administration of d-amphetamine (4 mg/kg, ip) increased glutamate release by 500% in WT mice, as compared to 300% in NTS2-/- mice, and 250% in NTS1-/- mice. Additionally, d-amphetamine injection caused a 4-fold increase in GABA release in both WT and NTS2-/- mice, but only a 2-fold increase in NTS1-/- mice. Therefore, NTS1 and NTS2 modulate basal release of d-serine and glutamate, and also d-amphetamine-induced GABA and glutamate release in striatum. These results provide further support for the involvement of NT receptors in the pathogenesis of schizophrenia and provide a better understanding of the imbalance of amino acid systems through investigation of a DA-based animal model.
AB - Neurotensin (NT) is a tridecapeptide that acts as a neuromodulator in the central nervous system mainly through two NT receptors: NTS1 and NTS2. The present study was done to determine the roles of NTS1 and NTS2 on amino acid release in striatum with the use of NTS1 or NTS2 knockout (-/-) mice given d-amphetamine. Both NTS1-/- and NTS2-/- mice had lower extracellular concentrations of d-serine in striatum than did wild type (WT) mice. NTS2-/- but not NTS1-/- mice also had significantly lower basal concentrations of glutamate in striatum as compared to that for WT mice. Systemic administration of d-amphetamine (4 mg/kg, ip) increased glutamate release by 500% in WT mice, as compared to 300% in NTS2-/- mice, and 250% in NTS1-/- mice. Additionally, d-amphetamine injection caused a 4-fold increase in GABA release in both WT and NTS2-/- mice, but only a 2-fold increase in NTS1-/- mice. Therefore, NTS1 and NTS2 modulate basal release of d-serine and glutamate, and also d-amphetamine-induced GABA and glutamate release in striatum. These results provide further support for the involvement of NT receptors in the pathogenesis of schizophrenia and provide a better understanding of the imbalance of amino acid systems through investigation of a DA-based animal model.
UR - http://www.scopus.com/inward/record.url?scp=77950949711&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77950949711&partnerID=8YFLogxK
U2 - 10.1016/j.neuropharm.2010.02.016
DO - 10.1016/j.neuropharm.2010.02.016
M3 - Article
C2 - 20193696
AN - SCOPUS:77950949711
SN - 0028-3908
VL - 58
SP - 1174
EP - 1178
JO - Neuropharmacology
JF - Neuropharmacology
IS - 7
ER -